Breaking Down Barriers to Improve Outcomes and Access to Integrated Continuous Glucose Monitoring Devices

This activity includes patient counseling videos.

Program Description

While the comorbidities and costs of diabetes are well known, persons with diabetes also experience psychological stress due to risk of hypoglycemia. This webinar will review clinical data supporting the use of integrated continuous glucose monitoring (iCGM) devices in decreasing risk of hypoglycemia in individuals living with diabetes. Despite data supporting iCGMs as the new standard of care for diabetes management, their uptake remains low, and pharmacists and pharmacy technicians are optimally positioned to identify persons with diabetes who would benefit from utilization of an iCGM device. Approaches to overcome current challenges with diabetes health literacy and access barriers affecting the uptake and use of iCGM devices will be examined. Patient counseling videos included throughout the activity will include detailed educational points for setting up a patient’s iCGM device with customizable settings, responding to alerts, and interpreting iCGM data. 

Target audience: Retail pharmacists and pharmacy technicians

Type of activity: Application for pharmacists; Knowledge for pharmacy technicians
Release date: March 8, 2023
Expiration date: May 8, 2023

Time to complete activity: 1.0 hour
Fee: Free

Educational Objectives

At the completion of this activity, pharmacists will be able to:

• Identify the role of integrated continuous glucose monitoring (iCGM) devices in improving quality of life and reducing psychological burden for persons with diabetes
• Analyze current challenges and access barriers affecting uptake of iCGM devices
• Exercise best practices to expand access and awareness about iCGM devices and improve the management of diabetes across patient populations 

At the completion of this activity, pharmacy technicians will be able to:

• Articulate the role of integrated continuous glucose monitoring (iCGM) devices in improving quality of life and reducing psychological burden for persons with diabetes
• Outline current challenges and access barriers affecting uptake of iCGM devices
• Recall ways to assist the pharmacist to expand access and spread awareness about iCGM devices

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity numbers 0290-0000-23-012-L01-P and 0290-0000-23-013-L01-T. The activity is available for CE credit through May 8, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Jessica L. Kerr, PharmD, CDCES

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Karleen Melody, PharmD; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta.

An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms